BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NANO MRNA Co.,Ltd. Logo
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
Japan
4571
NANOVIRICIDES, INC. Logo
Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.
United States of America
NNVC
Nautilus Biotechnology, Inc. Logo
Develops a proteome analysis platform to quantify proteins at the single-molecule level.
United States of America
NAUT
NeoImmuneTech, Inc. Logo
A clinical-stage biopharma developing T cell-focused immuno-therapeutics for diseases.
United States of America
950220
Neovacs Logo
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
France
ALNEV
NewAmsterdam Pharma Co N.V. Logo
A clinical-stage biopharma developing therapies for metabolic diseases with unmet needs.
United States of America
NAMS
NextGen Biomed Ltd. Logo
Develops novel therapeutic delivery systems and pain-free auto-injectors.
Israel
NXGN
NEXTURNBIOSCIENCE Co., LTD Logo
Manufacturer of CNC automatic lathes and ultra-precision components for various industries.
South Korea
089140
NFL Biosciences Logo
Biopharmaceutical company developing botanical drug candidates for addiction treatment.
France
ALNFL
NGeneBio Co., Ltd. Logo
Develops NGS-based molecular diagnostic products and software for oncology.
South Korea
354200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.